Mirae Asset Global Investments
MRNS

Mirae Asset Global Investments’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History

Mirae Asset Global Investments’s Portfolio MRNS Stock Details MRNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,992
Closed -$3.67K – 1701
2024
Q3 		$3.67K Buy
1,992
+352
+21% +$491 ﹤0.01% 1527
2024
Q2 		$2.02K Buy
+1,640
New +$4.1K ﹤0.01% 1508
2024
Q1 		– Sell
-25,444
Closed -$277K – 2690
2023
Q4 		$277K Buy
25,444
+174
+0.7% +$1.3K ﹤0.01% 2227
2023
Q3 		$203K Buy
25,270
+46
+0.2% +$383 ﹤0.01% 2289
2023
Q2 		$274K Buy
+25,224
New +$216K ﹤0.01% 2218

Other funds holding MRNS

BCM
Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
OBAM
ODDO BHF Asset Management Paris, France $2.54B AUM 41.83% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Mirae Asset Global Investments's MRNS Position: Q4 2024 in Review

Mirae Asset Global Investments sold out of Marinus Pharmaceuticals, Inc (MRNS) in Q4 2024, closing a stake of 1,992 shares — an estimated $3.67K sold.

Mirae Asset Global Investments first reported a position in MRNS in Q2 2023 and held it in 5 quarters. The position peaked at $277K in Q4 2023. 53 funds tracked by Wall St. Rank hold MRNS as of Q4 2024.

  • Mirae Asset Global Investments reported no remaining Marinus Pharmaceuticals, Inc position as of Q4 2024 after selling out during the quarter.
  • Mirae Asset Global Investments sold 1,992 Marinus Pharmaceuticals, Inc shares in Q4 2024, an estimated $3.67K.
  • Mirae Asset Global Investments first reported a position in Marinus Pharmaceuticals, Inc in Q2 2023 and held it in 5 quarters.
  • Mirae Asset Global Investments's Marinus Pharmaceuticals, Inc position peaked at $277K in Q4 2023.
  • 53 funds tracked by Wall St. Rank held Marinus Pharmaceuticals, Inc as of Q4 2024.

Based on Mirae Asset Global Investments's 13F filing for Q4 2024, filed 27 Jan 2025.